Isatuximab (Sarclisa) Report issue

Biologics mAb Orphan Drug FDA Approved FDA
AACT ChEMBL
Back

Drug Pricing Summary

VA Big4

$472.1100 - $2366.5600

VA FSS

$472.1100 - $2366.5600

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
isatuximab 100 mg / 5 mL (5 mL INJECTION) $472.1100 VA Big4
  • Sarclisa (1)
    		•  Sanofi Aventis U.S. LLC
    isatuximab 100 mg / 5 mL (5 mL INJECTION) $472.1100 VA FSS
  • Sarclisa (1)
    		•  Sanofi Aventis U.S. LLC
    isatuximab 500 mg / 25 mL (25 mL INJECTION) $2366.5600 VA Big4
  • Sarclisa (1)
    		•  Sanofi Aventis U.S. LLC
    isatuximab 500 mg / 25 mL (25 mL INJECTION) $2366.5600 VA FSS
  • Sarclisa (1)
    		•  Sanofi Aventis U.S. LLC

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue